Molracetam
2-[4-(4-methoxybenzoyl)piperazin-1-yl]-1-morpholin-4-ylethanone
Molracetam is a rare synthetic racetam with a morpholinyl-piperazinyl core and methoxybenzoyl substituent. No preclinical or human studies have been published; it exists only as a catalog compound and in registry/patent records.
Also known as:
Formula
C₁₈H₂₅N₃O₄
Category
Racetam / Piperazine-morpholine
Molar Mass
347.4 g/mol
Legal Status
No approval, research only
Chemical Profile
Mechanism of Action
No mechanism-of-action or preclinical cognitive evidence has been published for Molracetam. By class, it is presumably intended as a potential racetam-type synaptic or cholinergic modulator.
Evidence and Literature Status
Chemical Registries and Patent Mentions Only
No peer-reviewed, preclinical, or clinical research has been published for Molracetam. Its existence is documented in regulatory and chemical databases, including PubChem, ChEMBL, and FDA GSRS; as well as international patent databases.
Safety & Side Effects
No published animal, in vitro, or human data can be found as of 2024.
Regulatory & Legal Status
US/EU/International
- Not FDA/EU approved
- No controlled status; not marketed
- Listed only in chemical/compound registries
Note: Molracetam is not approved for any use. Research only.
History
Molracetam was likely synthesized in the late 1980s or early 1990s, assigned an INN, but never advanced to research or development beyond registry mention. No public preclinical/clinical results are available.
Premium Molracetam
Enhance your cognitive performance with science-backed, high-quality nootropics.
Benefits
- Novel piperazine-morpholine racetam scaffold
- Unique registry/patent chemistry
- Curiosity for SAR and chembio research
Considerations
- No animal, human, or in vitro research
- Never marketed or clinically studied
- Not for human use
Free shipping on orders above $50
Scientific References
- "Molracetam." PubChem Compound Summary, NCBI, CID 779179, 2024. https://pubchem.ncbi.nlm.nih.gov/compound/779179.
- "Molracetam." ChEMBL Compound Report, CHEMBL1717710, EBI, 2024. https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1717710/
- Patent listing for Molracetam structure, WIPO PATENTSCOPE.
- Molracetam GSRS Substance Record (FDA/NLM).
- "Molracetam", NCI Thesaurus Concept Report, C66180.
Information is for research, chemical and historical reference only. Not for human use. Last updated: 4/12/2025.